Literature DB >> 29538260

Impact of Mitochondrial Permeability on Endothelial Cell Immunogenicity in Transplantation.

Danh T Tran1,2, Scott Esckilsen2, Jennifer Mulligan3, Shikhar Mehrotra2, Carl Atkinson1,2,4, Satish N Nadig1,2,4.   

Abstract

BACKGROUND: Microvascular endothelial cells (ECs) are central to an allograft's immunogenicity. Cold ischemia and reperfusion injury associated with static cold storage and warm reperfusion activates ECs and increases the immunogenicity of the allograft. After reperfusion, mitochondrial permeability transition pore (mPTP) opening contributes to mitochondrial dysfunction in the allograft, which correlates to alloimmune rejection. Current understanding of this relationship, however, centers on the whole allograft instead of ECs. This study aimed to elucidate the relationship between EC mPTP opening and their immunophenotype.
METHODS: Mitochondrial metabolic fitness and glycolysis in ECs were assessed in parallel with metabolic gene microarray postreperfusion. NIM811 was used to inhibit mPTP opening to rescue mitochondrial fitness. The immunogenicity of NIM811-treated ECs was determined via levels of EC's proinflammatory cytokines and allogeneic CD8 T cell cocultures. Finally, EC surface expression of adhesion, costimulatory, coinhibitory, MHC-I molecules, and MHC-I machinery protein levels were characterized.
RESULTS: Genes for glycolysis, tricarboxylic acid cycle, fatty acid synthesis, gluconeogenesis were upregulated at 6 hours postreperfusion but either normalized or downregulated at 24 hours postreperfusion. As mitochondrial fitness was reduced, glycolysis increased during the first 6 hours postreperfusion. Endothelial cell treatment with NIM811 during the early postreperfusion period rescued mitochondrial fitness and reduced EC immunogenicity by decreasing CCL2, KC release, and VCAM-1, MHC-I, TAP1 expression.
CONCLUSIONS: Static cold storage and warm reperfusion leads to a reduction in mitochondrial fitness in microvascular ECs due to mPTP opening. Further, mPTP opening promotes increased EC immunogenicity that can be prevented by NIM811 treatment.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29538260      PMCID: PMC5962417          DOI: 10.1097/TP.0000000000002163

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  42 in total

1.  Early T cell response to allografts occurring prior to alloantigen priming up-regulates innate-mediated inflammation and graft necrosis.

Authors:  Tarek El-Sawy; Masayoshi Miura; Robert Fairchild
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

2.  Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells.

Authors:  Bart Everts; Eyal Amiel; Gerritje J W van der Windt; Tori C Freitas; Robert Chott; Kevin E Yarasheski; Erika L Pearce; Edward J Pearce
Journal:  Blood       Date:  2012-07-11       Impact factor: 22.113

3.  Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin.

Authors:  Allan D Kirk; Roslyn B Mannon; David E Kleiner; John S Swanson; Robert L Kampen; Linda K Cendales; Eric A Elster; Terri Wakefield; Christine Chamberlain; Steven C Hoffmann; Douglas A Hale
Journal:  Transplantation       Date:  2005-10-27       Impact factor: 4.939

Review 4.  Blood Vessels in Allotransplantation.

Authors:  P Abrahimi; R Liu; J S Pober
Journal:  Am J Transplant       Date:  2015-03-23       Impact factor: 8.086

5.  Ablation of Cyclophilin D Results in an Activation of FAK, Akt, and ERK Pathways in the Mouse Heart.

Authors:  Jelena Klawitter; Tamas Seres; Alexander Pennington; Jonathan-Thomas Beatty; Jost Klawitter; Uwe Christians
Journal:  J Cell Biochem       Date:  2017-04-12       Impact factor: 4.429

6.  Rapamycin inhibits IL-4--induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo.

Authors:  Holger Hackstein; Timucin Taner; Alan F Zahorchak; Adrian E Morelli; Alison J Logar; Andre Gessner; Angus W Thomson
Journal:  Blood       Date:  2003-01-16       Impact factor: 22.113

7.  Functional heterogeneity of mitochondria after cardiac cold ischemia and reperfusion revealed by confocal imaging.

Authors:  Andrey V Kuznetsov; Stefan Schneeberger; Oliver Renz; Hugo Meusburger; Valdur Saks; Yves Usson; Raimund Margreiter
Journal:  Transplantation       Date:  2004-03-15       Impact factor: 4.939

8.  Mitochondrial defects and heterogeneous cytochrome c release after cardiac cold ischemia and reperfusion.

Authors:  Andrey V Kuznetsov; Stefan Schneeberger; Rüdiger Seiler; Gerald Brandacher; Walter Mark; Wolfgang Steurer; Valdur Saks; Yves Usson; Raimund Margreiter; Erich Gnaiger
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-12-23       Impact factor: 4.733

Review 9.  The mitochondrial permeability transition: a current perspective on its identity and role in ischaemia/reperfusion injury.

Authors:  Andrew P Halestrap; Andrew P Richardson
Journal:  J Mol Cell Cardiol       Date:  2014-08-30       Impact factor: 5.000

10.  Rapamycin antagonizes TNF induction of VCAM-1 on endothelial cells by inhibiting mTORC2.

Authors:  Chen Wang; Lingfeng Qin; Thomas D Manes; Nancy C Kirkiles-Smith; George Tellides; Jordan S Pober
Journal:  J Exp Med       Date:  2014-02-10       Impact factor: 14.307

View more
  6 in total

1.  A clinically relevant murine model unmasks a "two-hit" mechanism for reactivation and dissemination of cytomegalovirus after kidney transplant.

Authors:  Zheng Zhang; Longhui Qiu; Shixian Yan; Jiao-Jing Wang; Paul M Thomas; Manoj Kandpal; Lihui Zhao; Andre Iovane; Xue-Feng Liu; Edward B Thorp; Qing Chen; Mary Hummel; Yashpal S Kanwar; Michael M Abecassis
Journal:  Am J Transplant       Date:  2019-05-14       Impact factor: 8.086

Review 2.  Reactive species-induced microvascular dysfunction in ischemia/reperfusion.

Authors:  Hong Yu; Ted Kalogeris; Ronald J Korthuis
Journal:  Free Radic Biol Med       Date:  2019-03-05       Impact factor: 7.376

3.  Modulating donor mitochondrial fusion/fission delivers immunoprotective effects in cardiac transplantation.

Authors:  Danh T Tran; Zhenxiao Tu; Ali Alawieh; Jennifer Mulligan; Scott Esckilsen; Kristen Quinn; Kamala Sundararaj; Caroline Wallace; Ryan Finnegan; Patterson Allen; Shikhar Mehrotra; Carl Atkinson; Satish N Nadig
Journal:  Am J Transplant       Date:  2021-11-08       Impact factor: 9.369

Review 4.  Nanotherapeutics in transplantation: How do we get to clinical implementation?

Authors:  Leah Plumblee; Carl Atkinson; Dinesh Jaishankar; Evan Scott; Gregory T Tietjen; Satish N Nadig
Journal:  Am J Transplant       Date:  2022-03-10       Impact factor: 9.369

Review 5.  Improving the ischemia-reperfusion injury in vascularized composite allotransplantation: Clinical experience and experimental implications.

Authors:  Jiqiang He; Umar Zeb Khan; Liming Qing; Panfeng Wu; Juyu Tang
Journal:  Front Immunol       Date:  2022-09-16       Impact factor: 8.786

Review 6.  T-cell Immunometabolism: Therapeutic Implications in Organ Transplantation.

Authors:  Danh T Tran; Kamala Sundararaj; Carl Atkinson; Satish N Nadig
Journal:  Transplantation       Date:  2021-11-01       Impact factor: 5.385

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.